• Publications
  • Influence

Claim Your Author Page
Ensure your research is discoverable on Semantic Scholar. Claiming your author page allows you to personalize the information displayed and manage your publications. Semantic Scholar automatically creates author pages based on data aggregated from public sources and our publisher partners.
  • B J Steinhoff, Elinor Ben-Menachem, +7 authors Antonio Laurenza
  • Medicine
  • Epilepsia
  • 2013 (First Publication: 1 August 2013)
  • PURPOSE Three phase III studies (304 [ClinicalTrials.gov identifier: NCT00699972], 305 [NCT00699582], 306 [NCT00700310]) evaluated perampanel, an α-amino-3-hydroxy-5-methyl-4-isoxazolepropionic acidContinue Reading
  • William E. S. Rosenfeld, Joan A. Conry, +7 authors Antonio Laurenza
  • Medicine
  • European journal of paediatric neurology : EJPN…
  • 2015 (First Publication: 1 July 2015)
  • OBJECTIVE Assess perampanel's efficacy and safety as adjunctive therapy in adolescents (ages 12-17) with drug-resistant partial seizures. METHODS Adolescent patients enrolled in multinational,Continue Reading
  • Gregory L. Krauss, Emilio Perucca, +7 authors Antonio Laurenza
  • Medicine
  • Epilepsia
  • 2013
  • PURPOSE To evaluate safety, tolerability, and seizure outcome data during long-term treatment with once-daily adjunctive perampanel (up to 12 mg/day) in patients with refractory partial-onsetContinue Reading
  • Alan B. Ettinger, Antonia LoPresti, +4 authors Antonio Laurenza
  • Medicine
  • Epilepsia
  • 2015 (First Publication: 3 July 2015)
  • Summary Objective Perampanel, a selective, noncompetitive α‐amino‐3‐hydroxy‐5‐methyl‐4‐isoxazolepropionic acid (AMPA) glutamate receptor antagonist, is indicated for adjunctive treatment of partialContinue Reading